Public Procurement in the COVID-19 crisis: opportunities and challenges

In their response to the urgency of the COVID-19 crisis, contracting authorities within Europe have experienced many challenges.

Despite the guidance issued by the EU on using the public procurement framework in an emergency situation such as COVID-19, and the exceptional measures taken at national level that have followed, many contracts have been awarded without the application of the public procurement rules and without any form of (ex-post) transparency.

The extreme and immediate needs of the healthcare sector including scarcity of medical supplies, supply interruptions, transport disruptions, protectionist measures, lockdowns and lack of EU manufacturing capacity have exposed the vulnerabilities of the European market. As time passes, it may arguably be more difficult to rely on extreme urgency and unforeseeable circumstances, especially during the roll out phase of vaccination programmes.

In this webinar, Bird & Bird’s public procurement specialists within the life sciences and healthcare sector discussed the big legal challenges faced within the EU around public procurement and addressed concerns and questions which could arise before the vaccination roll out process begins.

Related videos

What opportunities does the liberalisation of Medicinal...

July 29, 2020

Partner Niels Lutzhoeft explores the paradigm shift of opinions...

Brexit - What's next for Public Procurement?

February 11, 2020

Senior Associates Claire Gamage and Chris Murray take a look at the...

Key takeaways from the Eurotunnel v Dept Transport case

March 14, 2019

Associates Claire Gamage and Christopher Murray in our Procurement...